PL355113A1 - Nowe pochodne kwasu fusydowego - Google Patents

Nowe pochodne kwasu fusydowego

Info

Publication number: PL355113A1
Authority: PL; Poland
Prior art keywords: acid derivatives; fusidic acid; novel; novel fusidic; treatment
Prior art date: 1999-10-15

Application number

PL00355113A

Other languages

English (en)

Other versions

PL203312B1 (pl

Inventor

Tore Duvold

Daehne Welf Von

Original Assignee

Leo Pharmaceutical Products Ltd.A/S (Lovens Kemiske Fabrik Produktionsaktieselskab)

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

1999-10-15

Filing date

2000-10-12

Publication date

2004-04-05

2000-10-12 Application filed by Leo Pharmaceutical Products Ltd.A/S (Lovens Kemiske Fabrik Produktionsaktieselskab) filed Critical Leo Pharmaceutical Products Ltd.A/S (Lovens Kemiske Fabrik Produktionsaktieselskab)

2004-04-05 Publication of PL355113A1 publication Critical patent/PL355113A1/pl

2009-09-30 Publication of PL203312B1 publication Critical patent/PL203312B1/pl

Links

IECPWNUMDGFDKC-MZJAQBGESA-N fusidic acid Chemical class O[C@@H]([C@@H]12)C[C@H]3\C(=C(/CCC=C(C)C)C(O)=O)[C@@H](OC(C)=O)C[C@]3(C)[C@@]2(C)CC[C@@H]2[C@]1(C)CC[C@@H](O)[C@H]2C IECPWNUMDGFDKC-MZJAQBGESA-N 0.000 title 1
208000001860 Eye Infections Diseases 0.000 abstract 1
239000002253 acid Substances 0.000 abstract 1
208000011323 eye infectious disease Diseases 0.000 abstract 1
208000015181 infectious disease Diseases 0.000 abstract 1
239000000203 mixture Substances 0.000 abstract 1
239000008194 pharmaceutical composition Substances 0.000 abstract 1
206010040872 skin infection Diseases 0.000 abstract 1
230000000699 topical effect Effects 0.000 abstract 1

Classifications

- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07J—STEROIDS
- C07J9/00—Normal steroids containing carbon, hydrogen, halogen or oxygen substituted in position 17 beta by a chain of more than two carbon atoms, e.g. cholane, cholestane, coprostane
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P27/00—Drugs for disorders of the senses
- A61P27/02—Ophthalmic agents
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/04—Antibacterial agents
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07J—STEROIDS
- C07J13/00—Normal steroids containing carbon, hydrogen, halogen or oxygen having a carbon-to-carbon double bond from or to position 17

Landscapes

Health & Medical Sciences (AREA)
Chemical & Material Sciences (AREA)
Organic Chemistry (AREA)
General Health & Medical Sciences (AREA)
Public Health (AREA)
Veterinary Medicine (AREA)
Animal Behavior & Ethology (AREA)
Chemical Kinetics & Catalysis (AREA)
General Chemical & Material Sciences (AREA)
Medicinal Chemistry (AREA)
Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
Pharmacology & Pharmacy (AREA)
Life Sciences & Earth Sciences (AREA)
Oncology (AREA)
Bioinformatics & Cheminformatics (AREA)
Communicable Diseases (AREA)
Engineering & Computer Science (AREA)
Dermatology (AREA)
Ophthalmology & Optometry (AREA)
Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Agricultural Chemicals And Associated Chemicals (AREA)
Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
Saccharide Compounds (AREA)
Medicinal Preparation (AREA)
Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
Steroid Compounds (AREA)

PL355113A 1999-10-15 2000-10-12 Pochodne kwasu fusydowego, ich zastosowanie oraz kompozycja farmaceutyczna je zawierająca PL203312B1 (pl)

Applications Claiming Priority (2)

Application Number	Priority Date	Filing Date	Title
US15955799P	1999-10-15	1999-10-15
PCT/DK2000/000578 WO2001029061A1 (en)	1999-10-15	2000-10-12	Novel fusidic acid derivatives

Publications (2)

Publication Number	Publication Date
PL355113A1 true PL355113A1 (pl)	2004-04-05
PL203312B1 PL203312B1 (pl)	2009-09-30

Family

ID=22573055

Family Applications (1)

Application Number	Title	Priority Date	Filing Date
PL355113A PL203312B1 (pl)	1999-10-15	2000-10-12	Pochodne kwasu fusydowego, ich zastosowanie oraz kompozycja farmaceutyczna je zawierająca

Country Status (20)

Country	Link
US (1)	US6593319B1 (pl)
EP (1)	EP1232173B1 (pl)
JP (1)	JP2003512386A (pl)
KR (1)	KR100795321B1 (pl)
CN (1)	CN1157404C (pl)
AT (1)	ATE241640T1 (pl)
AU (1)	AU777352B2 (pl)
BR (1)	BR0014751A (pl)
CA (1)	CA2387600C (pl)
CZ (1)	CZ20021265A3 (pl)
DE (1)	DE60003074T2 (pl)
DK (1)	DK1232173T3 (pl)
ES (1)	ES2199867T3 (pl)
HU (1)	HUP0203454A3 (pl)
MX (1)	MXPA02003731A (pl)
NZ (1)	NZ518034A (pl)
PL (1)	PL203312B1 (pl)
PT (1)	PT1232173E (pl)
RU (1)	RU2257391C2 (pl)
WO (1)	WO2001029061A1 (pl)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
MY140194A (en) *	2003-07-16	2009-11-30	Leo Pharma As	Novel fusidic acid derivatives
US20060230643A1 (en) *	2005-03-23	2006-10-19	Michael Affleck	Footwear with additional comfort
RU2418806C2 (ru) *	2005-10-31	2011-05-20	Лео Фарма А/С	Получение кристаллического антибиотика
DE602006020063D1 (de)	2005-12-07	2011-03-24	Univ Ramot	Wirkstoffabgebende verbundkörper
UA111867C2 (uk) *	2011-11-11	2016-06-24	Аллерган, Інк.	ФАРМАЦЕВТИЧНА КОМПОЗИЦІЯ І СПОСІБ ЗАСТОСУВАННЯ ПОХІДНИХ 4-ПРЕГНЕН-11β-17-21-ТРІОЛ-3,20-ДІОНУ

Family Cites Families (12)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
DK135267A (pl)	1971-02-25
US4162259A (en)	1975-12-03	1979-07-24	Leo Pharmaceutical Products Ltd. A/S (Lovens Kemiske fabrik Produktionsaktienselskab)	Fusidic acid derivatives
US4259333A (en)	1977-10-28	1981-03-31	Leo Pharmaceutical Products Ltd. A/S (Lovens Kemiske Fabrik Produktionsaktieselskab)	Cephalosporines
GB2013084B (en)	1978-01-25	1982-07-28	Alcon Lab Inc	Ophthalmic drug dosage
DE2964471D1 (en)	1979-06-08	1983-02-17	Toko Yakuhin Kogyo Kk	Creamy preparation containing steroid and process for the preparation thereof
US4959358A (en) *	1983-06-06	1990-09-25	Beth Israel Hospital Assn.	Drug administration
US4548922A (en) *	1983-06-06	1985-10-22	Beth Israel Hospital	Drug administration
GB8500310D0 (en) *	1985-01-07	1985-02-13	Leo Pharm Prod Ltd	Pharmaceutical preparation
RU1499922C (ru) *	1987-12-25	1995-08-09	Государственный научный центр по антибиотикам	Способ получения фузидиевой кислоты и ее натриевой соли
IE892257A1 (en) *	1989-07-13	1991-02-13	Elan Corp	Anti-infective agent, process for its preparation and its¹use in therapy
US6103884A (en)	1996-03-27	2000-08-15	The University Of Michigan	Glycosylated analogs of fusidic acid
WO2002070537A2 (en) *	2001-03-08	2002-09-12	Leo Pharma A/S	Fusidic acid derivatives

2000
- 2000-10-12 NZ NZ518034A patent/NZ518034A/en unknown
- 2000-10-12 ES ES00967616T patent/ES2199867T3/es not_active Expired - Lifetime
- 2000-10-12 EP EP00967616A patent/EP1232173B1/en not_active Expired - Lifetime
- 2000-10-12 AU AU77728/00A patent/AU777352B2/en not_active Ceased
- 2000-10-12 PT PT00967616T patent/PT1232173E/pt unknown
- 2000-10-12 KR KR1020027004837A patent/KR100795321B1/ko not_active Expired - Fee Related
- 2000-10-12 BR BR0014751-6A patent/BR0014751A/pt not_active IP Right Cessation
- 2000-10-12 CA CA002387600A patent/CA2387600C/en not_active Expired - Fee Related
- 2000-10-12 CN CNB008141886A patent/CN1157404C/zh not_active Expired - Fee Related
- 2000-10-12 DE DE60003074T patent/DE60003074T2/de not_active Expired - Lifetime
- 2000-10-12 JP JP2001531859A patent/JP2003512386A/ja not_active Withdrawn
- 2000-10-12 CZ CZ20021265A patent/CZ20021265A3/cs unknown
- 2000-10-12 PL PL355113A patent/PL203312B1/pl not_active IP Right Cessation
- 2000-10-12 MX MXPA02003731A patent/MXPA02003731A/es active IP Right Grant
- 2000-10-12 HU HU0203454A patent/HUP0203454A3/hu unknown
- 2000-10-12 WO PCT/DK2000/000578 patent/WO2001029061A1/en not_active Ceased
- 2000-10-12 RU RU2002112986/04A patent/RU2257391C2/ru not_active IP Right Cessation
- 2000-10-12 US US09/787,539 patent/US6593319B1/en not_active Expired - Fee Related
- 2000-10-12 DK DK00967616T patent/DK1232173T3/da active
- 2000-10-12 AT AT00967616T patent/ATE241640T1/de not_active IP Right Cessation

Also Published As

Publication number	Publication date
BR0014751A (pt)	2002-07-02
HUP0203454A2 (hu)	2003-02-28
KR100795321B1 (ko)	2008-01-21
JP2003512386A (ja)	2003-04-02
EP1232173B1 (en)	2003-05-28
CZ20021265A3 (cs)	2003-02-12
PT1232173E (pt)	2003-10-31
ATE241640T1 (de)	2003-06-15
CA2387600A1 (en)	2001-04-26
CN1378554A (zh)	2002-11-06
DE60003074D1 (de)	2003-07-03
DK1232173T3 (da)	2003-09-29
RU2257391C2 (ru)	2005-07-27
DE60003074T2 (de)	2004-03-18
MXPA02003731A (es)	2003-12-11
EP1232173A1 (en)	2002-08-21
HUP0203454A3 (en)	2004-07-28
HK1050203A1 (en)	2003-06-13
WO2001029061A1 (en)	2001-04-26
CA2387600C (en)	2007-08-21
PL203312B1 (pl)	2009-09-30
CN1157404C (zh)	2004-07-14
AU7772800A (en)	2001-04-30
NZ518034A (en)	2003-10-31
US6593319B1 (en)	2003-07-15
KR20030022760A (ko)	2003-03-17
AU777352B2 (en)	2004-10-14
ES2199867T3 (es)	2004-03-01

Similar Documents

Publication	Publication Date	Title
YU83502A (sh)	2005-11-28	Nova farmaceutska smeša
CA2303498A1 (en)	2000-09-30	Dioxocyclopentyl hydroxamic acids
BR0014078A (pt)	2002-12-31	Inibidores de fator xa
MX9700885A (es)	1998-04-30	Nuevas heteroariloxazolidinonas.
MXPA04001256A (es)	2004-05-27	Productos de combinacion de derivados de propanolamina aril substituidos con otros ingredientes activos y su uso.
AU2001247968A1 (en)	2002-03-13	Use of asiatic acid or asiaticoside for treatment of cancer
AU5186799A (en)	2000-02-07	Peptides of il-2 and derivatives thereof and their use as therapeutic agents
AU3850600A (en)	2000-10-04	Dalda analogs and their use
TNSN04034A1 (en)	2006-06-01	Combined preparations, containing 1,4-benzothiepine-1,1-dioxide derivatives and other active substances, and the use thereof
WO1997004788A3 (en)	1997-03-27	Use of calendula glycosides for the treatment of psoriasis
TR199900661T2 (xx)	1999-06-21	Cilt enfeksiyonlar�n�n tedavisi amac�yla 1-hidroksi-2-piridonlar�n kullan�m�
AU4651700A (en)	2001-01-09	Salts of aminoimidazole carboxamide useful in the prevention and treatment of liver diseases
WO2003039453A3 (en)	2003-12-04	Novel benzoyl peroxide compositions for the treatment of dermatological disorders and methods for their use
PL346143A1 (en)	2002-01-28	Tan-1057 derivatives
TR200001102T2 (tr)	2000-08-21	İkameli tetrahidropirimidinen türevleri, üretimleri ve kullanımları.
BG101126A (en)	1997-09-30	The use of muramylpeptide compounds
MXPA03001455A (es)	2004-05-04	Compuestos de pirazol, composiciones farmaceuticas y metodos para modular o inhibir la actividad del amiloide-beta-peptido asociado a reticulo endoplasmico y l-3-hidroxiacil-coa-deshidrogenasa.
CA2340734A1 (en)	2000-06-22	Optically active pyridyl-4h-1,2,4-oxadiazine derivative and its use in the treatment of vascular diseases
WO2001057042A3 (de)	2001-12-27	4-pyridyl- und 2,4-pyrimidinyl-substituierte pyrrolderivate und ihre anwendung in der pharmazie
AU3862997A (en)	1998-02-20	Stable derivatives of ubiquinole, processes for their production and pharmaceutical use thereof
AU2001267561A1 (en)	2002-01-08	Combination preparations of 3-n-formylhydroxylaminopropyl phosphonic acid derivatives or 3-n-acetylhydroxylaminopropyl phosphonic acid derivatives combined withspecific pharmaceutical active agents
MXPA02003731A (es)	2003-12-11	Derivados novedosos de acido fusidico.
WO2002070537A3 (en)	2002-11-07	Fusidic acid derivatives
AU2566101A (en)	2001-07-09	Compounds and methods for the treatment of pain
AU2002212489A1 (en)	2002-05-15	Veterinary composition for the topical treatment of traumatized or inflamed skin

Legal Events

Date	Code	Title	Description
2011-12-30	LAPS	Decisions on the lapse of the protection rights	Effective date: 20101012